Company Overview
Snapshot
Founded in January 2023 by Karny Ilan, Gal Yanuka, and Shani Klein, Feminai operates with 1–10 employees. The company has raised $6 million across two funding rounds, with Vertex Ventures Israel and Fusion Fund participating. In January 2026, Feminai secured $6 million in Seed funding for its AI-powered at-home breast cancer screening solution.
Business overview
Feminai is dedicated to enhancing early breast cancer detection for women through its innovative home-based screening device. The company's core technology integrates this device with a personalized AI-based medical screening plan, aiming to provide efficient and safe diagnostic means. Feminai operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and diagnostics, leveraging artificial intelligence to serve the women's health market.
Strategic signal
In January 2026, Feminai successfully raised $6 million in Seed funding, a significant validation of its AI-powered at-home breast cancer screening solution. This capital infusion, with Vertex Ventures Israel and Fusion Fund participating, signals strong investor confidence in the company's technology and its potential to disrupt the diagnostics market by making early detection more accessible and personalized. This development positions Feminai for accelerated product development and market entry, indicating a positive trajectory for growth and innovation in femtech and digital healthcare.
Log in to access full profile ›Company Intelligence Q&A
- What is Feminai's primary mission?
- Feminai's mission is to provide women with efficient and safe means for early breast cancer detection, utilizing a home breast cancer screening device combined with a personalized AI-based medical screening plan.
- When was Feminai founded and by whom?
- Feminai was founded in January 2023 by co-founders Karny Ilan, Gal Yanuka, and Shani Klein.
- What significant funding did Feminai receive recently?
- In January 2026, Feminai raised $6 million in Seed funding for its AI-powered at-home breast cancer screening solution. Vertex Ventures Israel was a lead investor in this round, joined by Fusion Fund.
- Has Feminai received any non-equity funding?
- Yes, in October 2025, Feminai secured a grant from the Israel Innovation Authority.
- What was a key early recognition for Feminai's innovation?
- In January 2023, Feminai's home breast cancer screening device was recognized as the winning invention at the BizTEC entrepreneurship competition final event.